LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 20.33% ano a ano.
Virada para Prejuízo
O desempenho da empresa passou a ser negativo, com prejuízo anual mais recente de US$ .
Sobreavaliada
O PE mais recente da empresa é 41.59, em uma faixa percentil alta de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 60.49M ações, uma redução de 15.69% em relação ao trimestre anterior.
Mantido por HOTCHKIS & WILEY
O Super Investidor HOTCHKIS & WILEY possui 478.62K ações desta empresa.